Purpose
Negative Helicobacter pylori status has been identified as a poor prognostic factor for survival in gastric cancer (GC) patients who underwent surgery. The aim of this study was to examine the effect of H. pylori eradication on long-term outcomes after distal gastrectomy for GC.
Materials and Methods
We analyzed the survival of 169 distal GC patients enrolled in a prospective randomized trial evaluating histologic changes of gastric mucosa after H. pylori eradication in the remnant stomach. The outcomes measured were overall survival (OS) and GC recurrence rates.
Results
The median follow-up duration was 9.4 years. In the modified intention-to-treat analysis including patients who underwent H. pylori treatment (n=87) or placebo (n=82), 5-year OS rates were 98.9% in the treatment group and 91.5% in the placebo group, and KaplanMeier analysis showed no significant difference in OS (p=0.957) between groups. In multivariate analysis, no difference in overall mortality was observed between groups (adjusted hazard ratio [aHR] for H. pylori treatment, 0.75; p=0.495) or H. pylori-eradicated status (aHR for positive H. pylori status, 1.16; p=0.715), while old age, male sex, and advanced stage ≥ IIIa were independent risk factors. Six patients in the treatment group (6.9%) and seven patients in the placebo group (8.5%) had GC recurrences, and GC recurrence rates were not different according to H. pylori treatment (5-year GC recurrence rates, 4.6% in the treatment group vs. 8.5% in the placebo group; p=0.652).
Conclusion
H. pylori eradication for GC patients who underwent distal gastrectomy did not compromise long-term survival after surgery.
Citations
Citations to this article as recorded by
Relationship between Helicobacter pylori infection and programmed death-ligand 1 in gastric cancer: A meta-analysis Hong-Chang Yang, Cheng-Feng Fu, Li-Jun Qiao, Gen-He Long, Li-Fen Yang, Biao Yao World Journal of Clinical Oncology.2025;[Epub] CrossRef
The relationship between the eradication of Helicobacter pylori and the occurrence of stomach cancer: an updated meta-analysis and systemic review Zhouhan Wu, Yi Tang, Meiwen Tang, Zhoutong Wu, Yonghui Xu BMC Gastroenterology.2025;[Epub] CrossRef
Anti–Helicobacter pylori Treatment in Patients With Gastric Cancer After Radical Gastrectomy Zhoukai Zhao, Ruopeng Zhang, Guoming Chen, Man Nie, Feiyang Zhang, Xiaojiang Chen, Jun Lin, Zewei Chen, Feizhi Lin, Chengzhi Wei, Ziqi Zheng, Shenghang Ruan, Bowen Huang, Yingbo Chen, Runcong Nie JAMA Network Open.2024; 7(3): e243812. CrossRef
Helicobacter Pylori and Celiac Disease Antibody Positivity Have a Higher Prevalence in Patients With Distal Gastrectomy: A Cross-Sectional Retrospective Study Kubilay Issever, Ersin Kuloglu, Demet Sengul, Ali Muhtaroglu, Ahmet Cumhur Dulger Cureus.2023;[Epub] CrossRef
The influence of partial gastrectomy for gastric cancer on the spontaneous disappearance of Helicobacter pylori: A single‐center prospective study Senichiro Yanagawa, Nobuaki Fujikuni, Kazuaki Tanabe, Masahiro Nakahara, Toshio Noriyuki Cancer Reports.2023;[Epub] CrossRef
Positive H. pylori status predicts better prognosis of non-cardiac gastric cancer patients: results from cohort study and meta-analysis Zhifang Jia, Min Zheng, Jing Jiang, Donghui Cao, Yanhua Wu, Yuzheng Zhang, Yingli Fu, Xueyuan Cao BMC Cancer.2022;[Epub] CrossRef
Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu-Won Jung, Kui Son Choi Journal of Gastroenterology.2022; 57(7): 464. CrossRef
Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening toHelicobacter pyloriEradication in Korea Young-Il Kim, Il Ju Choi Journal of Gastric Cancer.2022; 22(3): 169. CrossRef
Helicobacter Pylori and Gastric Cancer Progression Marina A. Senchukova Current Microbiology.2022;[Epub] CrossRef
Identifying Factors Affecting Cancer-related Death in Patients with Adenocarcinoma Gastric Cancer; An Analysis in the Presence of Competing Risks Malihe Safari, Hossein Mahjub, Habib Esmaeili, Mohamad Abasi, Ghodratollah Roshanaei International Journal of Cancer Management.2021;[Epub] CrossRef
T stage and venous invasion are crucial prognostic factors for long-term survival of patients with remnant gastric cancer: a cohort study Kentaro Matsuo, Sang-Woong Lee, Ryo Tanaka, Yoshiro Imai, Kotaro Honda, Kohei Taniguchi, Hideki Tomiyama, Kazuhisa Uchiyama World Journal of Surgical Oncology.2021;[Epub] CrossRef
Tracking the Virulent Helicobacter pylori Strains Instead of Its Pan-Screening to Prevent Gastric Cancer Farid Rahimi, Amin Talebi Bezmin Abadi BioNanoScience.2020; 10(1): 315. CrossRef
Proton-pump inhibitor and amoxicillin-based triple therapy containing clarithromycin versus metronidazole for Helicobacter pylori: A meta-analysis Bo Li, Xiaoqian Lan, Li Wang, Jiani Zhao, Jingli Ding, Hao Ding, Jun Lei, Yiping Wei, Wenxiong Zhang Microbial Pathogenesis.2020; 142: 104075. CrossRef
Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years Yonghoon Choi, Nayoung Kim, Chang Yong Yun, Yoon Jin Choi, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Sang-Hoon Ahn, Do Joong Park, Hye Seung Lee, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim Gastric Cancer.2020; 23(6): 1051. CrossRef
Impact of the timing of Helicobacter pylori eradication on the risk of development of metachronous lesions after treatment of early gastric cancer: a population-based cohort study Hyun Ju Kim, Yun Jin Kim, Seung In Seo, Woon Geon Shin, Chan Hyuk Park Gastrointestinal Endoscopy.2020; 92(3): 613. CrossRef
Helicobacter pylori Eradication in Patients Undergoing Gastrectomy: Diagnosis and Therapy Youn I Choi, Jun-Won Chung The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2020; 20(3): 204. CrossRef
Helicobacter pylori Eradication in Adult Patients with Acute Idiopathic Thrombocytopenic Purpura (ITP) Minoosh Moghimi, Yousef Mortazavi, Saeed Razavi-Dizaji, Shahrbanoo Keyhanian, Zahra Ghadimi, Sahar Baba Ali, Saeideh Mazloomzadeh, Sattar Jafari, Reza Mansouri, Masoud Asadi-Khiavi Journal of Advances in Medical and Biomedical Research.2019; 27(124): 1. CrossRef
Helicobacter pylori
Therapy for the Prevention of Metachronous Gastric Cancer
Il Ju Choi, Myeong-Cherl Kook, Young-Il Kim, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Boram Park, Byung-Ho Nam New England Journal of Medicine.2018; 378(12): 1085. CrossRef
Helicobacter pyloriEradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials Bum Jun Kim, Hyeong Su Kim, Hyun Joo Jang, Jung Han Kim Gastroenterology Research and Practice.2018; 2018: 1. CrossRef
Do We Need to Retest of Helicobacter pylori Infection after Gastric Cancer Surgery? Sang Kil Lee Gut and Liver.2017; 11(2): 169. CrossRef
PURPOSE Increasing evidence suggests that polymorphisms in innate immunity genes are associated with Helicobacter pylori-induced inflammation and may influence susceptibility in developing noncardia gastric cancer. Therefore, we investigate the effect of polymorphisms of innate immunity genes and interactions with environmental factors in the Korean population. MATERIALS AND METHODS We genotyped four polymorphisms of TLR2 (rs1898830), TLR4 (rs10983755 and rs10759932), and CD14 (rs2569190) in a case-control study of 487 noncardia gastric cancer patients and 487 sex- and age-matched healthy controls. Polytomous logistic regression models were used to detect the effects of genetic polymorphisms and environmental factors, which were stratified by the histological type of gastric cancer. RESULTS TLR4 rs10983755 A carriers were found to have higher risk of intestinal-type noncarida gastric cancer than G homozygotes (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.01 to 1.97), but other genetic variants showed no association with the risk of noncardia gastric cancer. Among H. pylori-positive participants, smokers carrying TLR4 rs10983755 A had a higher risk of intestinal-type gastric cancer than nonsmoking TLR4 rs10983755 G homozygotes (OR, 4.28; 95% CI, 2.12 to 8.64).
In addition, compared with tap water, other drinking water sources during childhood were found to be associated with the elevated risk of intestinal-type gastric cancer, and these associations were slightly stronger among TLR4 rs10983755 A carriers. CONCLUSION The genetic polymorphisms of innate immunity genes are associated with the development of intestinal-type noncardia gastric cancer and these associations may differ in accordance to an exposure to certain environmental factors.
Citations
Citations to this article as recorded by
Association between Toll-like receptor 2 rs4696483 and rs1898830 polymorphisms and the risk of triple-negative breast cancer Rabeb M. Ghali, Sonia Zaied, Amira Daldoul, Perizat Kanabekova, Wassim Y. Almawi Gene.2024; 928: 148773. CrossRef
Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene Eglė Žilienė, Arturas Inčiūra, Rasa Ugenskienė, Elona Juozaitytė Diagnostics.2023; 13(12): 1999. CrossRef
Ranking and Prioritizing Risk Factors for Gastric Cancer Ali Reza Yusefi, Shima Bordbar, Gholamhossein Mehralian, Kamran Bagheri Lankarani, Mohammad Khammarnia, Zahra Kavosi, Peivand Bastani The Open Public Health Journal.2023;[Epub] CrossRef
Common variants in toll-like receptor family genes and risk of gastric cancer: a systematic review and meta-analysis Ayoub Al Othaim, Sulieman Ibraheem Shelash Al-Hawary, Hashem O. Alsaab, Sami G. Almalki, Mazin A. A. Najm, Ahmed Hjazi, Ali Alsalamy, Abbas Firras Almulla, Hamzeh Alizadeh Frontiers in Genetics.2023;[Epub] CrossRef
Association between EPHA5 methylation status in peripheral blood leukocytes and the risk and prognosis of gastric cancer Xu Han, Tianyu Liu, Jiabao Zhai, Chang Liu, Wanyu Wang, Chuang Nie, Qi Wang, Xiaojie Zhu, Haibo Zhou, Wenjing Tian PeerJ.2022; 10: e13774. CrossRef
Alleviation of Huntington pathology in mice by oral administration of food additive glyceryl tribenzoate Debashis Dutta, Moumita Majumder, Ramesh Kumar Paidi, Kalipada Pahan Neurobiology of Disease.2021; 153: 105318. CrossRef
Demethylation of the RB1 promoter concomitant with reactivation of TET2 and TET3 impairs gastric carcinogenesis in K19-Wnt1/C2mE transgenic mice Donghui Cao, Zhifang Jia, Yanhua Wu, Tongrong Su, Dan Zhao, Menghui Wu, Tetsuya Tsukamoto, Masanobu Oshima, Jing Jiang, Xueyuan Cao Life Sciences.2020; 263: 118580. CrossRef
Genetic Variability as a Regulator of TLR4 and NOD Signaling in Response to Bacterial Driven DNA Damage Response (DDR) and Inflammation: Focus on the Gastrointestinal (GI) Tract Evagelia Spanou, Polyxeni Kalisperati, Ioannis S. Pateras, Alexandros Papalampros, Alexandra Barbouti, Athanasios G. Tzioufas, Athanassios Kotsinas, Stavros Sougioultzis Frontiers in Genetics.2017;[Epub] CrossRef
Increased deaths from gastric cancer in communities living close to waste landfills Agostino Di Ciaula International Journal of Environmental Health Research.2016; 26(3): 281. CrossRef
Correlation of Serum Levels of Endostatin with Tumor Stage in Gastric Cancer: A Systematic Review and Meta-Analysis Zheng-Hua Wang, Zhi-Tu Zhu, Xu-Yang Xiao, Jin Sun BioMed Research International.2015; 2015: 1. CrossRef
Pattern-Recognition Receptors and Gastric Cancer Natalia Castaño-RodrÃguez, Nadeem O. Kaakoush, Hazel M. Mitchell Frontiers in Immunology.2014;[Epub] CrossRef